Livforsakringsbolaget Skandia Omsesidigt raised its stake in shares of The Allstate Co. (NYSE:ALL – Free Report) by 70.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 384 shares of the insurance provider’s stock after acquiring an additional 159 shares during the quarter. Livforsakringsbolaget Skandia Omsesidigt’s holdings in Allstate were worth $54,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also bought and sold shares of ALL. Vanguard Group Inc. boosted its position in Allstate by 11.5% during the 3rd quarter. Vanguard Group Inc. now owns 32,270,589 shares of the insurance provider’s stock valued at $3,595,266,000 after acquiring an additional 3,322,673 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its position in shares of Allstate by 123.7% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 5,540,295 shares of the insurance provider’s stock worth $751,264,000 after purchasing an additional 3,064,105 shares in the last quarter. Cowa LLC acquired a new stake in shares of Allstate in the 1st quarter worth $30,000. Norges Bank acquired a new stake in shares of Allstate in the 4th quarter worth $190,865,000. Finally, Invesco Ltd. boosted its position in shares of Allstate by 46.6% in the 3rd quarter. Invesco Ltd. now owns 4,121,941 shares of the insurance provider’s stock worth $459,225,000 after purchasing an additional 1,311,095 shares in the last quarter. Institutional investors own 76.47% of the company’s stock.
Allstate Stock Performance
NYSE ALL opened at $172.96 on Friday. The stock has a 50-day simple moving average of $163.84 and a two-hundred day simple moving average of $147.03. The firm has a market capitalization of $45.50 billion, a P/E ratio of -139.48, a PEG ratio of 0.40 and a beta of 0.52. The Allstate Co. has a fifty-two week low of $100.57 and a fifty-two week high of $174.57. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.37 and a current ratio of 0.37.
Allstate Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Monday, April 1st. Investors of record on Monday, March 4th were paid a $0.92 dividend. This represents a $3.68 annualized dividend and a dividend yield of 2.13%. The ex-dividend date of this dividend was Friday, March 1st. This is a positive change from Allstate’s previous quarterly dividend of $0.89. Allstate’s payout ratio is currently -296.77%.
Insider Activity at Allstate
In related news, CAO John C. Pintozzi sold 4,000 shares of Allstate stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $159.47, for a total value of $637,880.00. Following the completion of the transaction, the chief accounting officer now owns 10,736 shares in the company, valued at approximately $1,712,069.92. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, insider John E. Dugenske sold 31,000 shares of Allstate stock in a transaction dated Tuesday, March 26th. The stock was sold at an average price of $170.20, for a total value of $5,276,200.00. Following the completion of the transaction, the insider now owns 63,731 shares in the company, valued at approximately $10,847,016.20. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CAO John C. Pintozzi sold 4,000 shares of Allstate stock in a transaction dated Tuesday, February 27th. The shares were sold at an average price of $159.47, for a total value of $637,880.00. Following the completion of the transaction, the chief accounting officer now owns 10,736 shares of the company’s stock, valued at approximately $1,712,069.92. The disclosure for this sale can be found here. 1.80% of the stock is owned by company insiders.
Wall Street Analysts Forecast Growth
ALL has been the subject of a number of recent analyst reports. Evercore ISI raised their price objective on Allstate from $166.00 to $173.00 and gave the stock an “in-line” rating in a research report on Thursday, April 11th. Keefe, Bruyette & Woods raised their price objective on Allstate from $181.00 to $189.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 10th. Morgan Stanley raised their price objective on Allstate from $187.00 to $190.00 and gave the stock an “overweight” rating in a research report on Monday, April 15th. Roth Mkm raised their target price on Allstate from $175.00 to $200.00 and gave the stock a “buy” rating in a research note on Monday, April 8th. Finally, Raymond James raised their target price on Allstate from $155.00 to $180.00 and gave the stock a “strong-buy” rating in a research note on Monday, January 22nd. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $173.71.
Check Out Our Latest Stock Report on ALL
Allstate Company Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Read More
- Five stocks we like better than Allstate
- Most active stocks: Dollar volume vs share volume
- Comprehensive Analysis of PayPal Stock
- Investing in Construction Stocks
- Intuitive Surgical Stock Can Trend Much Higher This YearÂ
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.